Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
Experimental and Therapeutic Medicine
Join Editorial Board Propose a Special Issue
Print ISSN: 1792-0981 Online ISSN: 1792-1015
Journal Cover
August-2023 Volume 26 Issue 2

Full Size Image

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
August-2023 Volume 26 Issue 2

Full Size Image

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML

  • Supplementary Files
    • Supplementary_Data.pdf
Article Open Access

Outcomes of arteriovenous graft vs. fistula for haemodialysis access in the elderly: A systematic review and meta‑analysis

  • Authors:
    • Jia Li
    • Hua Lu
    • Zhen Xie
    • Qingchao Li
    • Hongguang Shi
  • View Affiliations / Copyright

    Affiliations: Department of Nephrology, Navy 971 Hospital, Qingdao, Shandong 266000, P.R. China
    Copyright: © Li et al. This is an open access article distributed under the terms of Creative Commons Attribution License.
  • Article Number: 399
    |
    Published online on: July 6, 2023
       https://doi.org/10.3892/etm.2023.12098
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:



Abstract

The impact of the type of vascular access on the outcomes in the elderly haemodialysis patients is still unclear. The goal of the present study was to compare survival outcomes in elderly haemodialysis patients who received either arteriovenous graft (AVG) or arteriovenous fistula (AVF). A systematic literature search was performed in EMBASE, Cochrane, MEDLINE, ScienceDirect and Google Scholar databases for papers published from January 1954 until January 2022. Risk of bias in the selected publications was assessed by Newcastle Ottawa scale or Cochrane risk of bias tool depending on the study design. Meta‑analysis was carried out using the random‑effects model. Data were reported as pooled odds ratio (OR) or hazard ratio (HR) with 95% confidence interval (CI). A total of 12 studies were included in the analysis. The majority of the studies had poor quality. Elderly patients receiving AVG had significantly worse survival rate compared with patients that received AVF for the haemodialysis access, with a pooled HR of 1.38 (95% CI, 1.24‑1.53; I2=79.9%). Pooled HR for access survival was 1.60 (95% CI, 1.54‑1.66; I2=0%). Pooled OR for primary patency rate, maturation failure and infections were 1.81 (95% CI, 0.73‑4.49; I2=79.2%), 0.33 (95% CI, 0.12‑0.91; I2=70.4%) and 9.74 (95% CI, 2.60‑36.49; I2=52.4%), respectively. These results suggested that in elderly patients undergoing haemodialysis, AVG was associated with reduced overall survival and access survival, and higher infection rate, compared with AVF. Notably, AVG was also associated with a lower risk of maturation failure, presenting a potential advantage in specific patient populations (study registration: PROSPERO, no. CRD42022313199).
View Figures

Figure 1

Figure 2

Figure 3

Figure 4

Figure 5

Figure 6

Figure 7

View References

1 

Liyanage T, Ninomiya T, Jha V, Neal B, Patrice HM, Okpechi I, Zhao MH, Lv J, Garg AX, Knight J, et al: Worldwide access to treatment for end-stage kidney disease: A systematic review. Lancet. 385:1975–1982. 2015.PubMed/NCBI View Article : Google Scholar

2 

Besarab A: Resolved: Fistulas are preferred to grafts as initial vascular access for dialysis. Pro. J Am Soc Nephrol. 19:1629–1633. 2008.PubMed/NCBI View Article : Google Scholar

3 

Vascular Access 2006 Work Group. Vascular access 2006 work group: Clinical practice guidelines for vascular access. Am J Kidney Dis. 48 (Suppl 1):S176–S247. 2006.PubMed/NCBI View Article : Google Scholar

4 

Ethier J, Mendelssohn DC, Elder SJ, Hasegawa T, Akizawa T, Akiba T, Canaud BJ and Pisoni RL: Vascular access use and outcomes: An international perspective from the dialysis outcomes and practice patterns study. Nephrol Dial Transplant. 23:3219–3226. 2008.PubMed/NCBI View Article : Google Scholar

5 

Lok CE: Fistula first initiative: Advantages and pitfalls. Clin J Am Soc Nephrol. 2:1043–1053. 2007.PubMed/NCBI View Article : Google Scholar

6 

Bikbov B, Purcell CA and Levey AS: HYPERLINK ‘https://www.researchgate.net/scientific-contributions/Mari-Smith-2131815162’. Smith M and Abdoli A: HYPERLINK ‘https://www.researchgate.net/profile/Molla-Abebe’. Abebe M, Adebayo O, Afarideh M, Agarwal S, Agudelo-Botero M, et al: Global, regional, and national burden of chronic kidney disease, 1990-2017: A systematic analysis for the global burden of disease study 2017. The Lancet. 395:709–733. 2020.PubMed/NCBI View Article : Google Scholar

7 

Cortés MJ, Viedma G, Perales MC, Borrego FJ, Borrego J, del Barrio PP, Cunquero JMG, Liébana A and Bañasco VP: Fistulae or catheter for elderly who start hemodialysis without permanent vascular access? Nefrologia. 25:307–314. 2005.PubMed/NCBI(In Spanish).

8 

Murea M and Satko S: Looking beyond ‘fistula first’ in the elderly on hemodialysis. Semin Dial. 29:396–402. 2016.PubMed/NCBI View Article : Google Scholar

9 

Arhuidese IJ, Cooper MA, Rizwan M, Nejim B and Malas MB: Vascular access for hemodialysis in the elderly. J Vasc Surg. 69:517–525.e1. 2018.PubMed/NCBI View Article : Google Scholar

10 

Bae E, Lee H, Kim DK, Oh KH, Kim YS, Ahn C, Han JS, Min SII, Min SK, Kim HC and Joo KW: Autologous arteriovenous fistula is associated with superior outcomes in elderly hemodialysis patients. BMC Nephrol. 19(306)2018.PubMed/NCBI View Article : Google Scholar

11 

Choi J, Ban TH, Choi BS, Baik JH, Kim BS, Kim YO, Park CW, Yang CW, Jin DC and Park HS: Comparison of vascular access patency and patient survival between native arteriovenous fistula and synthetic arteriovenous graft according to age group. Hemodial Int. 24:309–316. 2020.PubMed/NCBI View Article : Google Scholar

12 

Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, Shamseer L, Tetzlaff JM, Akl EA, Brennan SE, et al: The PRISMA 2020 statement: An updated guideline for reporting systematic reviews. BMJ. 372(n71)2021.PubMed/NCBI View Article : Google Scholar

13 

Wells G, Shea B, O'Connell D, Peterson J, Welch V, Losos M and Tugwell P: The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomized studies in meta- analysis. The Ottawa Hospital Research Institute. 21:2021.

14 

Sterne JAC, Savović J, Page MJ, Elbers RG, Blencowe NS, Boutron I, Cates CJ, Cheng HY, Corbett MS, Eldridge SM, et al: RoB 2: A revised tool for assessing risk of bias in randomised trials. BMJ. 366(l4898)2019.PubMed/NCBI View Article : Google Scholar

15 

Parmar MK, Torri V and Stewart L: Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints. Stat Med. 17:2815–2834. 1998.PubMed/NCBI View Article : Google Scholar

16 

Higgins JPT and Green S: Cochrane Handbook for Systematic Reviews of Interventions, 2022.

17 

Murea M, Geary RL, Houston DK, Edwards MS, Robinson TW, Davis RP, Hurie JB, Williams TK, Velazquez-Ramirez G, Bagwell B, et al: A randomized pilot study to evaluate graft versus fistula vascular access strategy in older patients with advanced kidney disease: Results of a feasibility study. Pilot Feasibility Stud. 6(86)2020.PubMed/NCBI View Article : Google Scholar

18 

Robinson T, Geary RL, Davis RP, Hurie JB, Williams TK, Velazquez-Ramirez G, Moossavi S, Chen H and Murea M: Arteriovenous fistula versus graft access strategy in older adults receiving hemodialysis: A pilot randomized trial. Kidney Med. 3:248–256.e1. 2021.PubMed/NCBI View Article : Google Scholar

19 

Woo K, Goldman DP and Romley JA: Early failure of dialysis access among the elderly in the era of fistula first. Clin J Am Soc Nephrol. 10:1791–1798. 2015.PubMed/NCBI View Article : Google Scholar

20 

Saleh T, Sumida K, Molnar MZ, Potukuchi PK, Thomas F, Lu JL, Gyamlani GG, Streja E, Kalantar-Zadeh K and Kovesdy CP: Effect of age on the association of vascular access type with mortality in a cohort of incident end-stage renal disease patients. Nephron. 137:57–63. 2017.PubMed/NCBI View Article : Google Scholar

21 

Jadlowiec CC, Mannion EM, Lavallee M and Brown MG: Hemodialysis access in the elderly: Outcomes among patients older than seventy. Ann Vasc Surg. 31:77–84. 2016.PubMed/NCBI View Article : Google Scholar

22 

Cui J, Steele D, Wenger J, Kawai T, Liu F, Elias N, Watkins MT and Irani Z: Hemodialysis arteriovenous fistula as first option not necessary in elderly patients. J Vasc Surg. 63:1326–1332. 2016.PubMed/NCBI View Article : Google Scholar

23 

Lee HS, Song YR, Kim JK, Joo N, Kim C, Kim HJ and Kim SG: Outcomes of vascular access in hemodialysis patients: Analysis based on the Korean national health insurance database from 2008 to 2016. Kidney Res Clin Pract. 38:391–398. 2019.PubMed/NCBI View Article : Google Scholar

24 

Xue JL, Dahl D, Ebben JP and Collins AJ: The association of initial hemodialysis access type with mortality outcomes in elderly Medicare ESRD patients. Am J Kidney Dis. 42:1013–1019. 2003.PubMed/NCBI View Article : Google Scholar

25 

Jhee JH, Hwang SD, Song JH and Lee SW: The impact of comorbidity burden on the association between vascular access type and clinical outcomes among elderly patients undergoing hemodialysis. Sci Rep. 9(18156)2019.PubMed/NCBI View Article : Google Scholar

26 

Ravani P, Palmer SC, Oliver MJ, Quinn RR, MacRae JM, Tai DJ, Pannu NI, Thomas C, Hemmelgarn BR, Craig JC, et al: Associations between hemodialysis access type and clinical outcomes: A systematic review. J Am Soc Nephrol. 24:465–473. 2013.PubMed/NCBI View Article : Google Scholar

27 

Bylsma LC, Gage SM, Reichert H, Dahl SLM and Lawson JH: Arteriovenous Fistulae for Haemodialysis: A systematic review and meta-analysis of efficacy and safety outcomes. Eur J Vasc Endovasc Surg. 54:513–522. 2017.PubMed/NCBI View Article : Google Scholar

28 

Almasri J, Alsawas M, Mainou M, Mustafa RA, Wang Z, Woo K, Cull DL and Murad MH: Outcomes of vascular access for hemodialysis: A systematic review and meta-analysis. J Vasc Surg. 64:236–243. 2016.PubMed/NCBI View Article : Google Scholar

29 

Palmer SC, McGregor DO, Macaskill P, Craig JC, Elder GJ and Strippoli GFM: Meta-analysis: Vitamin D compounds in chronic kidney disease. Ann Intern Med. 147:840–853. 2007.PubMed/NCBI View Article : Google Scholar

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
Li J, Lu H, Xie Z, Li Q and Shi H: Outcomes of arteriovenous graft vs. fistula for haemodialysis access in the elderly: A systematic review and meta‑analysis. Exp Ther Med 26: 399, 2023.
APA
Li, J., Lu, H., Xie, Z., Li, Q., & Shi, H. (2023). Outcomes of arteriovenous graft vs. fistula for haemodialysis access in the elderly: A systematic review and meta‑analysis. Experimental and Therapeutic Medicine, 26, 399. https://doi.org/10.3892/etm.2023.12098
MLA
Li, J., Lu, H., Xie, Z., Li, Q., Shi, H."Outcomes of arteriovenous graft vs. fistula for haemodialysis access in the elderly: A systematic review and meta‑analysis". Experimental and Therapeutic Medicine 26.2 (2023): 399.
Chicago
Li, J., Lu, H., Xie, Z., Li, Q., Shi, H."Outcomes of arteriovenous graft vs. fistula for haemodialysis access in the elderly: A systematic review and meta‑analysis". Experimental and Therapeutic Medicine 26, no. 2 (2023): 399. https://doi.org/10.3892/etm.2023.12098
Copy and paste a formatted citation
x
Spandidos Publications style
Li J, Lu H, Xie Z, Li Q and Shi H: Outcomes of arteriovenous graft vs. fistula for haemodialysis access in the elderly: A systematic review and meta‑analysis. Exp Ther Med 26: 399, 2023.
APA
Li, J., Lu, H., Xie, Z., Li, Q., & Shi, H. (2023). Outcomes of arteriovenous graft vs. fistula for haemodialysis access in the elderly: A systematic review and meta‑analysis. Experimental and Therapeutic Medicine, 26, 399. https://doi.org/10.3892/etm.2023.12098
MLA
Li, J., Lu, H., Xie, Z., Li, Q., Shi, H."Outcomes of arteriovenous graft vs. fistula for haemodialysis access in the elderly: A systematic review and meta‑analysis". Experimental and Therapeutic Medicine 26.2 (2023): 399.
Chicago
Li, J., Lu, H., Xie, Z., Li, Q., Shi, H."Outcomes of arteriovenous graft vs. fistula for haemodialysis access in the elderly: A systematic review and meta‑analysis". Experimental and Therapeutic Medicine 26, no. 2 (2023): 399. https://doi.org/10.3892/etm.2023.12098
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team